Sun Life Financial Inc Biomarin Pharmaceutical Inc Transaction History

Sun Life Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $46,960 - $52,860	-500 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $34,888 - $45,454	459 Added 1119.51%	500 $47,000
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $35,650 - $42,517	-459 Reduced 91.8%	41 $0
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $40,300 - $47,475	500	500 $47,000

623

181M

1.73M

1.73M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.